Abstract
Purpose
Depression is common among hemodialysis patients. Even in developed countries, the prevalence of depression and its relation to health-related quality of life (HRQOL) in dialysis patients has only been poorly investigated. Furthermore, similar reports from many developing countries such as Egypt are scarce. This might be due to cultural and social concerns. This study is intended to address this important issue.
Methods
This cross-sectional study was conducted at the dialysis unit of the Urology and Nephrology Center, Mansoura University, Egypt. Data of 76 chronic hemodialysis patients (mean age 43.2 ± 15 years; 54 males and 22 females) were retrieved. Psychiatric interview and psychometric assessment of depression and HRQOL (using an Arabic-adapted Beck Depression Inventory II and Short Form scale, respectively) were performed.
Results
Depression was diagnosed in 58 patients (76.3 %). Of them, 18 (23.7 %), 15 (19.7 %) and 25 patients (32.9 %) were suffering from mild, moderate and severe depression, respectively. Depressed dialysis patients group was comparable to the non-depressed group except for a higher prevalence of peripheral neuropathy (46.7 vs. 11.5 %; p = 0.034) and a less frequent use of iron therapy (52.7 vs. 86.7 %; p = 0.017). Except for role limitation due to physical problems, all HRQOL aspects were significantly worse among the whole group of depressed patients compared to the non-depressed group.
Conclusion
Depression is common among our Egyptian hemodialysis patients. It seems to adversely affect almost all aspects of HRQOL. Therefore, a regular combined nephrology/psychiatry approach should be central to the medical care of hemodialysis patients in order to accurately assess for depression among them. Moreover, large national studies to delineate the prevalence and impact of depression among Egyptian hemodialysis patients are needed.
Similar content being viewed by others
References
Ginieri-Coccossis M, Theofilou P, Synodinou C, Tomaras V, Soldatos C (2008) Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: Investigating differences in early and later years of current treatment. BMC Nephrol 14(9):14
Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL (2009) Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int 75(11):1223–1229
Lopes AA, Albert JM, Young EW, Satayathum S, Pisoni RL, Andreucci VE, Mapes DL, Mason NA, Fukuhara S, Wikstrom B, Saito A, Port FK (2004) Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int 66(5):2047–2053
Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA (2006) The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int 69(9):1662–1668
Unruh ML, Weisbord SD, Kimmel PL (2005) Health-related quality of life in nephrology research and clinical practice. Semin Dial 18(2):82–90
Kao TW, Lai MS, Tsai TJ, Jan CF, Chie WC, Chen WY (2009) Economic, social, and psychological factors associated with health-related quality of life of chronic hemodialysis patients in northern Taiwan: a multicenter study. Artif Organs 33(1):61–68
Joshi V (2014) Quality of life in end stage renal disease patients. World J Nephrol 3(4):308–316
Theofilou P (2011) Quality of life in patients undergoing hemodialysis or peritoneal dialysis treatment. J Clin Med Res 3(3):132–138
Duarte PS, Miyazaki MC, Blay SL, Sesso R (2009) Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int 76(4):414–421
Untas A, Aguirrezabal M, Chauveau P, Leguen E, Combe C, Rascle N (2009) Anxiety and depression in hemodialysis: validation of the Hospital Anxiety and Depression Scale (HADS). Nephrol Ther 5(3):193–200
Ibrahim S, El Salamony O (2008) Depression, quality of life and malnutrition-inflammation scores in hemodialysis patients. Am J Nephrol 28(5):784–791
Okasha A (2004) Focus on psychiatry in Egypt. BJ Psychiatry 185:266–272
Ghareeb AG (2000) Manual of the Arabic BDI-II. Angle Press, Cairo
Alansari BM (2005) Beck Depression Inventory (BDI-II) sourcebook of Personality Disorders Scales. The New Book Home Co., Kuwait
Coons SJ, Alabdulmohsin SA, Draugalis JR, Hays RD (1998) Reliability of an Arabic version of the RAND 36-Item Health Survey and its equivalence to the US-English version). Med Care 36:428–432
Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory–II. Psychological Corporation, San Antonio
Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB (1994) Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 3(5):329–338
Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Fishbane S, Strippoli GF (2013) Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 84(1):179–191
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (4th ed, text rev). Author, Washington, DC
Koo JR, Yoon JW, Kim SG, Lee YK, Oh KH, Kim GH, Kim HJ, Chae DW, Noh JW, Lee SK, Son BK (2003) Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis 41(5):1037–1042
van Manen JG, Korevaar JC, Dekker FW, Reuselaars MC, Boeschoten EW, Krediet RT, NECOSAD Study Group (2001) Changes in employment status in end-stage renal disease patients during their first year of dialysis. Perit Dial Int 21(6):595–601
Biyik Z, Solak Y, Atalay H, Gaipov A, Guney F, Turk S (2013) Gabapentin versus pregabalin in improving sleep quality and depression in hemodialysis patients with peripheral neuropathy: a randomized prospective crossover trial. Int Urol Nephrol 45:831–837
Schepers E, Speer T, Bode-Böger SM, Fliser D, Kielstein JT (2014) Dimethylarginines ADMA and SDMA: the real water-soluble small toxins? Semin Nephrol 34(2):97–105
Kielstein JT, Suntharalingam M, Perthel R, Rong S, Martens-Lobenhoffer J, Jäger K, Bode-Böger SM, Nave H (2012) Asymmetric dimethylarginine may mediate increased heat pain threshold in experimental chronic kidney disease. Nephrol Dial Transplant 27(3):899–902
Kielstein H, Suntharalingam M, Perthel R, Song R, Schneider SM, Martens-Lobenhoffer J, Jäger K, Bode-Böger SM, Kielstein JT (2015) Role of the endogenous nitric oxide inhibitor ADMA and BDNF in depression and behavioural changes: clinical and preclinical data in chronic kidney disease. Nephrol Dial Transpl.doi:10.1093/ndt/gfv253
Gill P, Lowes L (2014) Renal transplant failure and disenfranchised grief: participants’experiences in the first year post-graft failure. J. Nurs Stud, Int. doi:10.1016/j.ijnurstu.2014.01.012
Soni RK, Weisbord SD, Unruh ML (2010) Health-related quality of life outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 19:153–159
Bautovich A, Katz I, Smith M, Loo CK, Harvey SB (2014) Depression and chronic kidney disease: a review for clinicians. Aust N Z J Psychiatry 48(6):530–541
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest
Rights and permissions
About this article
Cite this article
Donia, A.F., Zaki, N.F., Elassy, M. et al. Study of depression and quality of life among hemodialysis patients: an Egyptian experience. Int Urol Nephrol 47, 1855–1862 (2015). https://doi.org/10.1007/s11255-015-1091-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-015-1091-0